Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Pulmonary Hypertension

  Free Subscription


1 Am J Respir Cell Mol Biol
1 Arch Bronconeumol
1 Arch Soc Esp Oftalmol (Engl Ed)
1 ARP Rheumatol
1 BMC Pulm Med
1 Br J Pharmacol
1 Can J Cardiol
1 Circ J
1 Clin Liver Dis
1 Cureus
1 Curr Opin Pediatr
1 Curr Opin Pulm Med
1 Diagn Interv Imaging
1 ESC Heart Fail
1 Eur J Heart Fail
2 Eur J Pharmacol
2 Eur Respir J
1 Eur Respir Rev
1 Exp Physiol
1 Front Endocrinol (Lausanne)
1 Front Immunol
1 Heart Lung
1 High Alt Med Biol
1 Hypertens Res
1 Immun Inflamm Dis
1 Int J Biol Macromol
1 Int J Tuberc Lung Dis
2 Interv Cardiol Clin
1 Iran J Med Sci
1 J Am Heart Assoc
1 J Cardiothorac Vasc Anesth
1 J Cardiovasc Pharmacol
1 J Cardiovasc Transl Res
1 J Perinatol
1 Korean Circ J
1 Math Biosci
1 Medicine (Baltimore)
1 Nagoya J Med Sci
1 Neoreviews
3 Pulm Circ
1 Pulmonology
1 Respir Res
1 Rev Esp Cardiol (Engl Ed)
1 Rev Port Cardiol
1 Rheum Dis Clin North Am
1 Rheumatology (Oxford)
1 Sci Rep
1 Transl Res
1 Zhonghua Nei Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Cell Mol Biol

  1. RIBEUZ HL, Willer AS, Chevalier B, Sancho M, et al
    Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
    Am J Respir Cell Mol Biol. 2024;71:95-109.
    PubMed         Abstract available

    Arch Bronconeumol

  2. RECCHIONI T, Manzi G, Mihai A, Vizza CD, et al
    Is Cardiopulmonary Exercise Test Really Representative of Pulmonary Arterial Hypertension Patients' Quality of Life?
    Arch Bronconeumol. 2024;60:458-459.

    Arch Soc Esp Oftalmol (Engl Ed)

  3. GARZA-GARZA LA, Villarreal-Martinez P, Garza-Leon M
    Untreated combined persistent fetal vasculature with "coralliform" cataract in a Hispanic 21 year-old male.
    Arch Soc Esp Oftalmol (Engl Ed). 2024;99:300-303.
    PubMed         Abstract available

    ARP Rheumatol

  4. SAMI H, Sami F, Razok A, Dasgupta M, et al
    Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.
    ARP Rheumatol. 2024;3:95-100.
    PubMed         Abstract available

    BMC Pulm Med

  5. YANG L, Luo D, Huang T, Li X, et al
    Echocardiographic assessment for cardiopulmonary function in patients with congenital heart disease-related pulmonary arterial hypertension.
    BMC Pulm Med. 2024;24:306.
    PubMed         Abstract available

    Br J Pharmacol

  6. OKNINSKA M, Paterek A, Grzanka M, Zajda K, et al
    Myo-inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline-induced pulmonary hypertension in the rat.
    Br J Pharmacol. 2024 Jul 1. doi: 10.1111/bph.16482.
    PubMed         Abstract available

    Can J Cardiol

  7. FRANCOIS P, Sebastien B
    Collagen Triple Helix Repeat-Containing Protein 1: More Than Just a Novel Biomarker for Right Ventricular Involvement in Pulmonary Hypertension.
    Can J Cardiol. 2024 Jul 1:S0828-282X(24)00514-2. doi: 10.1016/j.cjca.2024.

    Circ J

  8. KILICKIRAN AVCI B, Seyahi E, Polat F, Kolak Z, et al
    Role of Optical Coherence Tomography in Vasculitis-Associated Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Circ J. 2024 Jun 28. doi: 10.1253/circj.CJ-24-0254.
    PubMed         Abstract available

    Clin Liver Dis

  9. BOMMENA S, Fallon MB
    Pulmonary Complications of Portal Hypertension.
    Clin Liver Dis. 2024;28:467-482.
    PubMed         Abstract available


  10. KHALIL S, Tabowei G, Kaur M, Dadzie SK, et al
    Effect of Pulmonary Hypertension on Survival Outcomes in Patients With Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Cureus. 2024;16:e58540.
    PubMed         Abstract available

    Curr Opin Pediatr

  11. MICHEL-MACIAS C, Hebert A, Altit G
    Optimizing management of chronic pulmonary hypertension in preterm infants: strategies for a complex population.
    Curr Opin Pediatr. 2024 Jun 27. doi: 10.1097/MOP.0000000000001383.
    PubMed         Abstract available

    Curr Opin Pulm Med

  12. ZEDER K, Douschan P, Foris V, Sassmann T, et al
    The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases.
    Curr Opin Pulm Med. 2024 Jul 4. doi: 10.1097/MCP.0000000000001096.
    PubMed         Abstract available

    Diagn Interv Imaging

  13. VALDEOLMILLOS E, Sakhi H, Tortigue M, Audie M, et al
    4D flow cardiac MRI to assess pulmonary blood flow in patients with pulmonary arterial hypertension associated with congenital heart disease.
    Diagn Interv Imaging. 2024;105.
    PubMed         Abstract available

    ESC Heart Fail

  14. COLAK A, Kumral Z, Sezgin D, Simsek GO, et al
    The prognostic value of right ventricular outflow tract velocity time integral in patients with pulmonary hypertension.
    ESC Heart Fail. 2024 Jul 3. doi: 10.1002/ehf2.14934.
    PubMed         Abstract available

    Eur J Heart Fail

  15. REDDY YNV, Miranda WR, Jain CC, Borlaug BA, et al
    Haemodynamic contributors to pulmonary hypertension across the spectrum of adult congenital heart disease.
    Eur J Heart Fail. 2024 Jul 2. doi: 10.1002/ejhf.3366.
    PubMed         Abstract available

    Eur J Pharmacol

  16. WANG X, Cui L, Wang Y, Zeng Z, et al
    Mechanistic investigation of wogonin in delaying the progression of endothelial mesenchymal transition by targeting the TGF-beta1 pathway in pulmonary hypertension.
    Eur J Pharmacol. 2024;978:176786.
    PubMed         Abstract available

  17. DAI X, Liu Y, Wu Y, Wang S, et al
    DYZY01 alleviates pulmonary hypertension via inhibiting endothelial cell pyroptosis and rescuing endothelial dysfunction.
    Eur J Pharmacol. 2024;978:176785.
    PubMed         Abstract available

    Eur Respir J

  18. BUDHRAM B, Zamanian RT, Weatherald J
    Moving the needle on proteasome inhibitor-induced pulmonary arterial hypertension: a definite maybe.
    Eur Respir J. 2024;63:2400946.

  19. WEATHERALD J, Hemnes AR, Maron BA, Mielniczuk LM, et al
    Phenotypes in Pulmonary Hypertension.
    Eur Respir J. 2024 Jul 4:2301633. doi: 10.1183/13993003.01633-2023.
    PubMed         Abstract available

    Eur Respir Rev

  20. LE BOZEC A, Korb-Savoldelli V, Boiteau C, Dechartres A, et al
    Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review.
    Eur Respir Rev. 2024;33:240006.
    PubMed         Abstract available

    Exp Physiol

  21. MOHAMMAD M, Hartmann JP, Carlsen J, Greve AM, et al
    Prognostic value of pulmonary diffusing capacity for carbon monoxide and ventilation-perfusion SPECT findings in pulmonary arterial hypertension.
    Exp Physiol. 2024;109:1040-1050.
    PubMed         Abstract available

    Front Endocrinol (Lausanne)

  22. LIU Z, Fu Q, Yu Q, Ma X, et al
    Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003-2018.
    Front Endocrinol (Lausanne). 2024;15:1418835.
    PubMed         Abstract available

    Front Immunol

  23. BOTONI FA, Lambertucci JR, Santos RAS, Muller J, et al
    Functional autoantibodies against G protein-coupled receptors in hepatic and pulmonary hypertensions in human schistosomiasis.
    Front Immunol. 2024;15:1404384.
    PubMed         Abstract available

    Heart Lung

  24. FREIRE TC, Ferreira MS, De Angelis K, Paula-Ribeiro M, et al
    Respiratory, cardiovascular and musculoskeletal mechanisms involved in the pathophysiology of pulmonary hypertension: An updated systematic review of preclinical and clinical studies.
    Heart Lung. 2024;68:81-91.
    PubMed         Abstract available

    High Alt Med Biol

  25. TANG XG, Wei ZD, Wang X, Zhang R, et al
    Letter to the Editor: T-Wave Inversion in Leads V1-V3 as a Crucial Indicator of High-Altitude Pulmonary Hypertension among Young Chinese Males at 4,820 m: A Report of Two Cases.
    High Alt Med Biol. 2024 Jul 3. doi: 10.1089/ham.2024.0093.

    Hypertens Res

  26. USMAN PP AS, Sekar D
    microRNA-based electrochemical biosensor for early detection of pulmonary arterial hypertension.
    Hypertens Res. 2024;47:2000-2002.

    Immun Inflamm Dis

  27. CHEN X, Yan Z, Pan Q, Zhang C, et al
    Bibliometric analysis of T-cells immunity in pulmonary hypertension from 1992 to 2022.
    Immun Inflamm Dis. 2024;12:e1280.
    PubMed         Abstract available

    Int J Biol Macromol

  28. NING S, Guo X, Zhu Y, Li C, et al
    The mechanism of NRF2 regulating cell proliferation and mesenchymal transformation in pulmonary hypertension.
    Int J Biol Macromol. 2024 Jun 27:133514. doi: 10.1016/j.ijbiomac.2024.133514.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  29. SONAGLIONI A, Caminati A, Zompatori M, Cassandro R, et al
    TAPSE/sPAP ratio can be used to predict pulmonary hypertension in fibrosing interstitial lung disease.
    Int J Tuberc Lung Dis. 2024;28:362-364.

    Interv Cardiol Clin

  30. NASRI A, Bashir R, Lakhter V
    Management of Complications of Balloon Pulmonary Angioplasty.
    Interv Cardiol Clin. 2023;12.
    PubMed         Abstract available

  31. ELHAGE HASSAN M, Vinales J, Perkins S, Sandesara P, et al
    Pathogenesis, Diagnosis, and Management of Chronic Thromboembolic Pulmonary Hypertension.
    Interv Cardiol Clin. 2023;12.
    PubMed         Abstract available

    Iran J Med Sci

  32. MAHDAVI M, Shahzadi H, Ghasemnezhad M, Hoseinzadeh Moghadam S, et al
    Pulmonary Capillary Hemangiomatosis as a Rare Underlying Cause of Primary Pulmonary Hypertension: A Case Report in an Adolescent.
    Iran J Med Sci. 2024;49:394-398.
    PubMed         Abstract available

    J Am Heart Assoc

  33. LOKHORST C, van der Werf S, Berger RMF, Douwes JM, et al
    Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.
    J Am Heart Assoc. 2024;13:e034151.
    PubMed         Abstract available

    J Cardiothorac Vasc Anesth

  34. SUAREZ-SIPMANN F, Sanchez Giralt JA, Magana Bru I, Perez Lucendo A, et al
    Synergistic Effects of Lung Recruitment and Positive End-expiratory Pressure Titration Guided by Electrical Impedance Tomography and Inhaled Nitric Oxide in Severe Postoperative Pulmonary Hypertension.
    J Cardiothorac Vasc Anesth. 2024 May 6:S1053-0770(24)00317.

    J Cardiovasc Pharmacol

  35. LUZ DE CASTRO A, Ortiz VD, Hickmann AR, Lacerda DS, et al
    J Cardiovasc Pharmacol. 2024 May 4. doi: 10.1097/FJC.0000000000001572.
    PubMed         Abstract available

    J Cardiovasc Transl Res

  36. ZHANG J, Huang WQ, Zhang YR, Liang N, et al
    Upregulation of eIF2alpha by m(6)A modification accelerates the proliferation of pulmonary artery smooth muscle cells in MCT-induced pulmonary arterial hypertension rats.
    J Cardiovasc Transl Res. 2024;17:598-608.
    PubMed         Abstract available

    J Perinatol

  37. SANTELICES F, Masoli D, Kattan J, Toso A, et al
    Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.
    J Perinatol. 2024 Jul 4. doi: 10.1038/s41372-024-02015.
    PubMed         Abstract available

    Korean Circ J

  38. PARK TK, Chang SA, Yang JH, Kwon W, et al
    Programmed Follow-up and Quality Control of Treatment Techniques Enhance Chronic Thromboembolic Pulmonary Hypertension Management: Lessons From a Multidisciplinary Team.
    Korean Circ J. 2024 Jun 3. doi: 10.4070/kcj.2024.0021.
    PubMed         Abstract available

    Math Biosci

  39. COLUNGA A, Carlson B, Olufsen MS
    The importance of incorporating ventricular-ventricular interaction (VVI) in the study of pulmonary hypertension.
    Math Biosci. 2024 Jun 27:109242. doi: 10.1016/j.mbs.2024.109242.
    PubMed         Abstract available

    Medicine (Baltimore)

  40. MA H, Gao JM, Wang J, Huang LY, et al
    Pulmonary tumor thrombotic microangiopathy: Two case reports and literature review.
    Medicine (Baltimore). 2024;103:e38618.
    PubMed         Abstract available

    Nagoya J Med Sci

  41. IMAI R, Adachi S, Yoshida M, Shimokata S, et al
    Clinical usefulness of endothelial progenitor cells in predicting the efficacy of riociguat in chronic thromboembolic pulmonary hypertension.
    Nagoya J Med Sci. 2024;86:292-303.
    PubMed         Abstract available


  42. MAIA PD, Abman SH, Mandell E
    Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: Basing Care on Physiology.
    Neoreviews. 2024;25:e415-e433.
    PubMed         Abstract available

    Pulm Circ

  43. SKORO-SAJER N, Sheares K, Forfia P, Heresi GA, et al
    Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY).
    Pulm Circ. 2024;14:e12406.
    PubMed         Abstract available

  44. AVITABILE CM, Mota JP, Yeaman KM, Andrieux SJ, et al
    Creating a digital approach for promoting physical activity in pediatric pulmonary hypertension: A framework for future interventions.
    Pulm Circ. 2024;14:e12402.
    PubMed         Abstract available

  45. KIKO T, Asano R, Endo H, Nishi N, et al
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension.
    Pulm Circ. 2024;14:e12409.
    PubMed         Abstract available


  46. LICHTBLAU M, Saxer S, Muller J, Appenzeller P, et al
    Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial.
    Pulmonology. 2024;30:362-369.
    PubMed         Abstract available

    Respir Res

  47. WU D, Lin Y, Yang M, Li H, et al
    Tissue factor regulates autophagy in pulmonary artery endothelial cells from chronic thromboembolic pulmonary hypertension rats via the p38 MAPK-FoxO1 pathway.
    Respir Res. 2024;25:261.
    PubMed         Abstract available

    Rev Esp Cardiol (Engl Ed)

  48. ROLDAN GOMEZ FJ, Aranda Fraustro A, Gomez Soto L, Pulido Zamudio T, et al
    Heritable pulmonary arterial hypertension in rats with spontaneous systemic hypertension.
    Rev Esp Cardiol (Engl Ed). 2024;77:587-588.

    Rev Port Cardiol

  49. INACIO CAZEIRO D, Azaredo Raposo M, Guimaraes T, Lousada N, et al
    Chronic thromboembolic pulmonary hypertension: A comprehensive review of pathogenesis, diagnosis, and treatment strategies.
    Rev Port Cardiol. 2024 Jun 28:S0870-2551(24)00187.
    PubMed         Abstract available

    Rheum Dis Clin North Am

    Pulmonary Hypertension Associated with Connective Tissue Disease.
    Rheum Dis Clin North Am. 2024;50:359-379.
    PubMed         Abstract available

    Rheumatology (Oxford)

  51. MORIYA H, Kato M, Hisada R, Ninagawa K, et al
    The chest CT signs for pulmonary veno-occlusive disease correlate with pulmonary haemodynamics in systemic sclerosis.
    Rheumatology (Oxford). 2024;63:1868-1873.
    PubMed         Abstract available

    Sci Rep

  52. HOLDA MK, Razny U, Sordyl M, Goralska J, et al
    Autophagy and ubiquitin-dependent proteolysis processes in left ventricular mass loss in pulmonary arterial hypertension.
    Sci Rep. 2024;14:15133.
    PubMed         Abstract available

    Transl Res

  53. YUAN S, Li S, Ruan J, Liu H, et al
    Chronic kidney disease and pulmonary hypertension: progress in diagnosis and treatment.
    Transl Res. 2024 Jul 1:S1931-5244(24)00138-5. doi: 10.1016/j.trsl.2024.
    PubMed         Abstract available

    Zhonghua Nei Ke Za Zhi

  54. DING YJ, Zhang L, Li QY
    [Advances in early diagnosis of non-thromboembolic tumor related pulmonary vascular disease].
    Zhonghua Nei Ke Za Zhi. 2024;63:712-715.

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.